胸腔积液沉淀物在恶性胸腔积液诊断中的临床应用价值

背景与目的恶性胸腔积液(malignant pleural effusion,MPE)是原发于胸膜或转移至胸膜的恶性肿瘤造成的胸腔积液。MPE患者预后差,应在减少病人痛苦的前提下,准确而快速的明确MPE的性质及病因,为后续治疗提供有效依据。方法 103例患者应用自然静止法或血凝集法制得胸水沉淀物,结合HE染色及免疫组化染色,在诊断MPE上与其他方法相比较。结果 103例MPE中,胸腔积液沉淀物方法确诊90例(诊断率87.4%);32例仅通过沉淀物诊断,74例指出病理类型,23例明确原发灶;与71例同时行有创方法比较,诊断率为81.7%与87.3%;对比液基细胞学,检出率为86.7%和44.0%...

Full description

Saved in:
Bibliographic Details
Published in中国肺癌杂志 Vol. 20; no. 6; pp. 395 - 401
Main Author 王欣同 程方圆 钟殿胜 张丽沙 孟凡路 邵宜 于涛
Format Journal Article
LanguageChinese
Published 天津医科大学总医院肿瘤科, 天津,300052 2017
Subjects
Online AccessGet full text
ISSN1009-3419
1999-6187
DOI10.3779/j.issn.1009-3419.2017.06.05

Cover

Abstract 背景与目的恶性胸腔积液(malignant pleural effusion,MPE)是原发于胸膜或转移至胸膜的恶性肿瘤造成的胸腔积液。MPE患者预后差,应在减少病人痛苦的前提下,准确而快速的明确MPE的性质及病因,为后续治疗提供有效依据。方法 103例患者应用自然静止法或血凝集法制得胸水沉淀物,结合HE染色及免疫组化染色,在诊断MPE上与其他方法相比较。结果 103例MPE中,胸腔积液沉淀物方法确诊90例(诊断率87.4%);32例仅通过沉淀物诊断,74例指出病理类型,23例明确原发灶;与71例同时行有创方法比较,诊断率为81.7%与87.3%;对比液基细胞学,检出率为86.7%和44.0%。结论胸腔积液沉淀物方法不仅可以增加细胞学诊断率且与其他有创方法诊断率近乎一致,同样可确定MPE病理类型及原发灶,是有创方法的较佳补充,甚至对于部分患者胸水沉淀物是唯一确诊方法。
AbstractList 背景与目的恶性胸腔积液(malignant pleural effusion,MPE)是原发于胸膜或转移至胸膜的恶性肿瘤造成的胸腔积液。MPE患者预后差,应在减少病人痛苦的前提下,准确而快速的明确MPE的性质及病因,为后续治疗提供有效依据。方法 103例患者应用自然静止法或血凝集法制得胸水沉淀物,结合HE染色及免疫组化染色,在诊断MPE上与其他方法相比较。结果 103例MPE中,胸腔积液沉淀物方法确诊90例(诊断率87.4%);32例仅通过沉淀物诊断,74例指出病理类型,23例明确原发灶;与71例同时行有创方法比较,诊断率为81.7%与87.3%;对比液基细胞学,检出率为86.7%和44.0%。结论胸腔积液沉淀物方法不仅可以增加细胞学诊断率且与其他有创方法诊断率近乎一致,同样可确定MPE病理类型及原发灶,是有创方法的较佳补充,甚至对于部分患者胸水沉淀物是唯一确诊方法。
背景与目的 恶性胸腔积液(malignant pleural effusion,MPE)是原发于胸膜或转移至胸膜的恶性肿瘤造成的胸腔积液.MPE患者预后差,应在减少病人痛苦的前提下,准确而快速的明确MPE的性质及病因,为后续治疗提供有效依据.方法 103例患者应用自然静止法或血凝集法制得胸水沉淀物,结合HE染色及免疫组化染色,在诊断MPE上与其他方法相比较.结果 103例MPE中,胸腔积液沉淀物方法确诊90例(诊断率87.4%);32例仅通过沉淀物诊断,74例指出病理类型,23例明确原发灶;与71例同时行有创方法比较,诊断率为81.7%与87.3%;对比液基细胞学,检出率为86.7%和44.0%.结论 胸腔积液沉淀物方法不仅可以增加细胞学诊断率且与其他有创方法诊断率近乎一致,同样可确定MPE病理类型及原发灶,是有创方法的较佳补充,甚至对于部分患者胸水沉淀物是唯一确诊方法.
Abstract_FL Background and objective Malignant pleural effusion (MPE) is due tumor which arises from the me-sothelium or metastases from tumor origniating other sites. Generally, the prognosis of MPE is poor, in the premise of reduc-ing the pain of patients, as soon as possible make clear the property of pleural effusion and cause of the disesease, rightly and quickly, providing effective information for subsequent treatment. Methods The cell block of 103 patients by using natural sedimentation or plasma coagulation method combined with HE staining and immunohistochemical staining method maked clear diagnosis and compared with other methods. Results 90 patients were diagnosed by cell block section from 103 patients who had MPE (diagnostic rate 87.4%); 32 cases were diagnosed by cell block section only, 74 cases pointed out that the patho-logical type , 23 cases even pointed out the primary lesions; 71 cases examined other invasive methods at the same time, the di-agnostic rate was 87.3% and 81.7%; the detection rate of cell block section and cytological smear in detecting malignant tumor cells was 86.7%and 44.0% respectively. Conclusion Cell block can not only increase the diagnosis, in contrast to cytological smear, and own the same diagnostic rate compared with other invasive methods, but also can confirm pathological type and primary lesion; especially, for other invasive methods, cell block method is a preferable complementary method, and that cell block method maybe the only way for some patients.
Author 王欣同 程方圆 钟殿胜 张丽沙 孟凡路 邵宜 于涛
AuthorAffiliation 天津医科大学总医院肿瘤科,天津300052
AuthorAffiliation_xml – name: 天津医科大学总医院肿瘤科, 天津,300052
Author_FL Diansheng ZHONG
Lisha ZHANG
Yi SHAO
Fanlu MENG
Tao YU
Fangyuan CHENG
Xintong WANG
Author_FL_xml – sequence: 1
  fullname: Xintong WANG
– sequence: 2
  fullname: Fangyuan CHENG
– sequence: 3
  fullname: Diansheng ZHONG
– sequence: 4
  fullname: Lisha ZHANG
– sequence: 5
  fullname: Fanlu MENG
– sequence: 6
  fullname: Yi SHAO
– sequence: 7
  fullname: Tao YU
Author_xml – sequence: 1
  fullname: 王欣同 程方圆 钟殿胜 张丽沙 孟凡路 邵宜 于涛
BookMark eNpNkE9LAlEUxR9hkFpfohatZrpv3j_fMqQyENq4l-fMG1PqWQ4RuTLKha6HFtFeW4ggoWJ9HGfGj9GEBW3OuXB-9144OZQxLaMROsBgEyHkUdNuBIGxMYC0CMXSdgALG7gNbAtlsZTS4rggMun8h-ygXBA0AbgjCc2i0vppse6FyXASz6bxtB_Pu0n_PXobxY-zuDv8n64ng_hlvFqMk9fn1eIjWg6iZZiEo9XnPOp-7aJtX10Feu_X86hyelIplqzyxdl58bhsuUwyS3IipOQFDJRgn3BfU-0KxYEzJZgmnhI1xbVyvVQ8l3IAKj3l-DVNHUJrJI8ON2fvlfGVqVebrbu2SR9WO3VfdTo_BUC6xVJyf0O6ly1Tv22k7E27ca3aD1UuHEa5KDDyDaTVeQo
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3779/j.issn.1009-3419.2017.06.05
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Clinical Value of Cell Block in the Diagnosis of Malignant Pleural Effusion
DocumentTitle_FL Clinical Value of Cell Block in the Diagnosis of Malignant Pleural Effusion
EISSN 1999-6187
EndPage 401
ExternalDocumentID zgfazz201706005
672546785
GroupedDBID ---
-05
04C
29R
2B.
2C~
2RA
2WC
3V.
5GY
5VS
6PF
92F
92I
92L
AAWTL
ABUWG
ACGFS
AFKRA
ALMA_UNASSIGNED_HOLDINGS
BENPR
BPHCQ
BVBZV
C1A
CCEZO
CCPQU
CIEJG
CQIGP
CW9
DIK
E3Z
EBD
EIHBH
EMOBN
EOJEC
F5P
GROUPED_DOAJ
HYE
IPNFZ
KQ8
KWQ
OBODZ
OK1
PIMPY
PQQKQ
PROAC
RIG
RNS
RPM
TCJ
TGQ
U1G
U5O
W91
~WA
4A8
93N
PGMZT
PHGZM
PHGZT
PMFND
PSX
ID FETCH-LOGICAL-c595-9637996810431f36fe4ec7a6065a75e3da7ba6eacd6eadc460049da2fbe4234b3
ISSN 1009-3419
IngestDate Thu May 29 03:56:17 EDT 2025
Wed Feb 14 10:01:01 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Clinical value
恶性胸腔积液
临床价值
免疫组化染色
自然静止法
Natural sedimentation
Plasma coagulation method
Malignant pleural effusion
血液凝集法
Imunohistochemical staining
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c595-9637996810431f36fe4ec7a6065a75e3da7ba6eacd6eadc460049da2fbe4234b3
Notes Background and objective Malignant pleural effusion(MPE) is due tumor which arises from the mesothelium or metastases from tumor origniating other sites. Generally, the prognosis of MPE is poor, in the premise of reducing the pain of patients, as soon as possible make clear the property of pleural effusion and cause of the disesease, rightly and quickly, providing effective information for subsequent treatment. Methods The cell block of 103 patients by using natural sedimentation or plasma coagulation method combined with HE staining and immunohistochemical staining method maked clear diagnosis and compared with other methods. Results 90 patients were diagnosed by cell block section from 103 patients who had MPE(diagnostic rate 87.4%); 32 cases were diagnosed by cell block section only, 74 cases pointed out that the pathological type, 23 cases even pointed out the primary lesions; 71 cases examined other invasive methods at the same time, the diagnostic rate was 87.3% and 81.7%; the detection rate of cell blo
PageCount 7
ParticipantIDs wanfang_journals_zgfazz201706005
chongqing_primary_672546785
PublicationCentury 2000
PublicationDate 2017
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – year: 2017
  text: 2017
PublicationDecade 2010
PublicationTitle 中国肺癌杂志
PublicationTitleAlternate Chinese Journal of Lung Cancer
PublicationTitle_FL Chinese Journal of Lung Cancer
PublicationYear 2017
Publisher 天津医科大学总医院肿瘤科, 天津,300052
Publisher_xml – name: 天津医科大学总医院肿瘤科, 天津,300052
SSID ssj0062934
ssib002262905
ssib044765436
ssib001103766
ssib038074678
ssib051369142
Score 2.1212714
Snippet 背景与目的恶性胸腔积液(malignant pleural effusion,MPE)是原发于胸膜或转移至胸膜的恶性肿瘤造成的胸腔积液。MPE患者预后差,应在减少病人痛苦的前提下,准确而快速的明...
背景与目的 恶性胸腔积液(malignant pleural effusion,MPE)是原发于胸膜或转移至胸膜的恶性肿瘤造成的胸腔积液.MPE患者预后差,应在减少病人痛苦的前提下,准确而快速的明...
SourceID wanfang
chongqing
SourceType Aggregation Database
Publisher
StartPage 395
SubjectTerms 临床价值
免疫组化染色
恶性胸腔积液
自然静止法
血液凝集法
Title 胸腔积液沉淀物在恶性胸腔积液诊断中的临床应用价值
URI http://lib.cqvip.com/qk/91098A/201706/672546785.html
https://d.wanfangdata.com.cn/periodical/zgfazz201706005
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0062934
  issn: 1009-3419
  databaseCode: KQ8
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0062934
  issn: 1009-3419
  databaseCode: DOA
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0062934
  issn: 1009-3419
  databaseCode: DIK
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssib044765436
  issn: 1009-3419
  databaseCode: M~E
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0062934
  issn: 1009-3419
  databaseCode: RPM
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: East & South Asia Database (ProQuest)
  customDbUrl:
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0062934
  issn: 1009-3419
  databaseCode: BVBZV
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/eastsouthasia
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0062934
  issn: 1009-3419
  databaseCode: BENPR
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JSxxBFC5cQHIJWYkxESGpUxjTS3Utx-6ZFgkoIRjwNvSqeBizmMucDEkOeh5yCLlrDiJIUDH5Oc7yM_JeVU07CUFMoClqefXVq1fT815VV70i5HGWKScXnNeEV8gay7ykJhUuw-VlIrJUpUWOX3SXlvniS_ZsNVgdG__tdMlWOp-1_3qu5H9GFfJgXPGU7D-MbAUKGRCH8YUQRhjCK40xjSWVPo2kjgRUMRoLGsKzQGNOI3g8HfGoVDoicGcD0EAyhByoUqehxCLpIj1GHES4ErLEpAwxR3EaNmjMsApGBFUhlczmRAzbikJNrCMGEEJsHWgi5A2KoHV72fbGsI8VJrABZA3NkocgiKCorGsGGpiJ4AtUVcpV9zWmMkKSEPrqaxgHKj3RPZK2DPiPhgKRHMoUVR5VurdhjKBGIgrrQSMA5Qw717AyVkqXAatYD_oC-C7Wi1BuGhP5DjRRbKCYlkpshaqi0VUYc9zUqgz8vIRe8YxGNXno24G71pSwesZzRt6nUaXhm2tGrf3BzOLOn6oNHUNq1YYNzFeN4uZEoT3QBhcavdpnyQVedyBkME4mPcEZqIDJKF5-_uLCYsZzoqMzeI976kIF4HUECDBMMybwMHJFH7g-Vy6rPLZBZbORY8jfFHlkmX96Cevo2GR9s7X2Gsw1fXquVSattRFDb-UGuW5naHOhed1ukrH2-i0ytWT3oNwmi4MPp4NPnf7eYe_4qHe00zvZ7u98637d770_7m3vjZYODnd7nw_OTw_6Xz6en37vnu12zzr9zv75j5Pu9s87ZGUhXqkv1ux9JLUswBtNuS-UQv99YHSXPi8LVmQi4WDEJyIo_DwRacLBkMkhyDPGcfadJ16ZFjBnYal_l0y0NlvFPTLnZqVfwlwGvUIznpVgNQu3KHynAJM1TYJpMlPJo_nKuJ1pVoM5TeashJr2z-hts71WJu22Z7xhOcH9SwFmyDWkNCuJD8jE1pt3xUOwrbfSWfv7mNVrU78AobWiKA
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%83%B8%E8%85%94%E7%A7%AF%E6%B6%B2%E6%B2%89%E6%B7%80%E7%89%A9%E5%9C%A8%E6%81%B6%E6%80%A7%E8%83%B8%E8%85%94%E7%A7%AF%E6%B6%B2%E8%AF%8A%E6%96%AD%E4%B8%AD%E7%9A%84%E4%B8%B4%E5%BA%8A%E5%BA%94%E7%94%A8%E4%BB%B7%E5%80%BC&rft.jtitle=%E4%B8%AD%E5%9B%BD%E8%82%BA%E7%99%8C%E6%9D%82%E5%BF%97&rft.au=%E7%8E%8B%E6%AC%A3%E5%90%8C+%E7%A8%8B%E6%96%B9%E5%9C%86+%E9%92%9F%E6%AE%BF%E8%83%9C+%E5%BC%A0%E4%B8%BD%E6%B2%99+%E5%AD%9F%E5%87%A1%E8%B7%AF+%E9%82%B5%E5%AE%9C+%E4%BA%8E%E6%B6%9B&rft.date=2017&rft.issn=1009-3419&rft.eissn=1999-6187&rft.volume=20&rft.issue=6&rft.spage=395&rft.epage=401&rft_id=info:doi/10.3779%2Fj.issn.1009-3419.2017.06.05&rft.externalDocID=672546785
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F91098A%2F91098A.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzgfazz%2Fzgfazz.jpg